novel transcript, antisense to BET1L (ENSG00000255229)

This entry does not refer to a validated receptor, enzyme, transporter, or other protein-based therapeutic target. “Novel transcript, antisense to BET1L” (ENSG00000255229) is a predicted non-coding RNA gene identified by Ensembl and captured in gene annotation databases such as GeneCards[1]. Its exact biological role is undetermined, but as an antisense RNA, it could potentially regulate the expression of the sense BET1L gene via antisense interactions, such as mRNA stability, splicing, or translation. There is no evidence from current literature or reference databases that this antisense RNA is involved as a direct disease gene or pharmacological intervention point[1]. Key points: - This gene does not encode a protein or function as a classical druggable target. - Information and mechanistic insight refer primarily to its relationship with the sense BET1L gene, which is a vesicle-SNARE protein implicated in Golgi function, vesicular transport, and, emerging evidence suggests, disease associations such as ALS and cancer[2][3][4]. - Any disease roles, biomarkers, or mechanistic actions listed for BET1L do not directly apply to this antisense transcript unless future studies reveal a functional regulatory impact mediated through the antisense mechanism. Issues/Limitations: - This is not a protein or druggable receptor/enzyme; thus, if you intend to retrieve data on therapeutic targets, this entry is likely invalid for that context (is_incorrect: true)[1].

Other names

novel transcript antisense to BET1LENSG00000255229